BioSpace News Archive

Quest Diagnostics Incorporated (NYSE: DGX), the world’s leading provider of diagnostic information services, announced today financial results for the third quarter ended September 30, 2022.

NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter and nine-month period ended September 30, 2022.

Agios Pharmaceuticals, Inc. today announced the company will host a conference call and live webcast on Thursday, November 3, 2022, at 8:00 a.m. ET to report its third quarter 2022 financial results and other business highlights.

Gibraltar Industries, Inc. announced today that it expects to release its third quarter 2022 financial results at approximately 7:30 a.m. ET on Thursday, November 3, 2022.

Recludix Pharma, a leader in platform approaches to discover inhibitors of challenging cancer and inflammatory disease targets, today announced the appointment of Paul A. Smith, Ph.D., as senior vice president of biology.

X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel small molecule therapeutics to benefit patients with diseases of the immune system, today announced that it will be reporting financial results for the third quarter ended September 30, 2022 on November 3, 2022.

NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL, NXGLW), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, announced today that it has developed a new, proprietary hydrogel eye patch to treat amblyopia.

Creative Medical Technology Holdings, Inc. announced today that through predominantly internal and collaborative development, it has produced an allogenic Cell Line called AlloStem.

GI OnDEMAND ®, gastroenterology’s leading multidisciplinary virtual integrated care platform announced a partnership with Mindset Health, the creator of Nerva, a 6-week gut-directed hypnotherapy program, delivered through a mobile app to help patients with irritable bowel syndrome better manage their symptoms.

Medifast (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTA VIA® , will announce financial results for the third quarter ended September 30, 2022 on Thursday, November 3, 2022, after market close.